Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pacemaker therapy in heart failure]

M Hochleitner1

  • 1Medizinischen Universitätsklinik, Innsbruck.

Wiener Medizinische Wochenschrift (1946)
|July 9, 1998
PubMed
Summary
This summary is machine-generated.

Pacemaker therapy, specifically DDD-pacemakers with short AV-time, may improve heart failure symptoms in carefully selected patients. Optimizing AV-time individually is crucial for enhancing hemodynamics and heart function.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Gender aspects in cardiovascular diseases].

Zeitschrift fur Gerontologie und Geriatrie·2013
Same author

Calibrated nanoscale capacitance measurements using a scanning microwave microscope.

The Review of scientific instruments·2010
Same author

Coronary heart disease: sexual bias in referral for coronary angiogram. How does it work in a state-run health system?

Journal of women's health & gender-based medicine·2000
Same author

Aura phenomena during syncope.

European neurology·1997
Same author

Improvement of cardiac function in patients with severe congestive heart failure and coronary artery disease by dual chamber pacing with shortened AV delay.

Pacing and clinical electrophysiology : PACE·1994
Same author

Dual-chamber pacing in patients with end-stage ischaemic cardiomyopathy.

Lancet (London, England)·1993
Same journal

Necrotizing fasciitis of the thigh-a devastating sign of intestinal perforation.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Regenerative therapies in rehabilitation with interfaces with occupational medicine, geriatrics, and oncology: the example of extracorporeal shock wave therapy.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Cerebral toxoplasmosis in patients with peripheral B-cell lymphoma : A case series and a literature review.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Post-pandemic rebound of rotavirus and adenovirus in pediatric gastroenteritis: a 6-year antigen-based surveillance study from Turkey.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

Neuroaxis involvement in Chikungunya virus infection: a retrospective case series.

Wiener medizinische Wochenschrift (1946)·2026
Same journal

A complicated case of a spinal Scedosporium apiospermum infection with a favorable outcome-case report.

Wiener medizinische Wochenschrift (1946)·2026
See all related articles

Area of Science:

  • Cardiology
  • Biomedical Engineering

Context:

  • Drug therapy is standard for heart failure, but pacemaker therapy for left ventricular failure remains controversial.
  • Previous studies on DDD-pacemakers with short AV-time have yielded mixed results for congestive heart failure.

Purpose:

  • To evaluate the effectiveness of pacemaker therapy, specifically short AV-time pacing, in patients with congestive heart failure.
  • To investigate the potential benefits of optimizing AV-time for hemodynamic improvement and functional classification.

Summary:

  • Pacemaker therapy is not a general recommendation for left ventricular failure but can benefit carefully selected patients with congestive heart failure.
  • Studies show short AV-time pacing can increase left ventricular ejection fraction, improve NYHA classification, and reduce mitral regurgitation.

Related Experiment Videos

  • The proposed mechanism involves optimizing AV-contraction to enhance ventricular filling and ejection fraction.

    • Impact:

    • Individualized AV-time optimization using echocardiography, Doppler sonography, and ergometry is essential for patient selection and treatment success.
    • This approach may improve hemodynamics and functional status in patients with congestive heart failure and high NYHA classification.
    • Further research is needed to identify the precise patient subgroups who will benefit most from this tailored pacemaker therapy.